Use of the AnaConDa<sup>™</sup> anaesthetic delivery system in ICU

Elliot, S.; Berridge, J. C.; Mallick, A.

doi:10.1111/j.1365-2044.2007.05161.x

Cited by 4 publications

(3 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Mostly, authors report benefits-but this beneficial effect is not unquestioned. 21 Isoflurane appears to be the preferred anesthetic because of its safety profile, but sevoflurane or halothane has also been described. 22 The use of volatile anesthetics outside the operating room is limited by organizational and structural requirements, as the use of anesthesia ventilators in an intensive care unit requires the constant deployment of trained personnel.…”

Section: Discussionmentioning

confidence: 99%

“…Evidence for the use of volatile anesthetics in acute asthma exists mainly in case reports or small single‐center studies. Mostly, authors report benefits–but this beneficial effect is not unquestioned 21 . Isoflurane appears to be the preferred anesthetic because of its safety profile, but sevoflurane or halothane has also been described 22 .…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

VV‐ECMO as bridge and safety net for successful therapeutic polypragmasy in a case of influenza‐triggered near‐fatal asthma

Kowalewski,

Schnürer,

Kopp

et al. 2023

Clinical Case Reports

View full text Add to dashboard Cite

Key Clinical MessageIn near‐fatal asthma, the combination of ECMO therapy and isoflurane application via an intensive care ventilator with an anesthetic conservation device represents a therapeutic combination in seemingly hopeless clinical situations.AbstractWe report a case of an adult patient with near‐fatal asthma, who was implanted venovenous extracorporeal membrane oxygenation in an extern hospital before transfer to our tertiary center. After 13 days and various therapeutic approaches, including inhaled isoflurane therapy via an anesthetic‐conserving device, the patient was decannulated and extubated 3 days later.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

VV‐ECMO as bridge and safety net for successful therapeutic polypragmasy in a case of influenza‐triggered near‐fatal asthma

Kowalewski,

Schnürer,

Kopp

et al. 2023

Clinical Case Reports

View full text Add to dashboard Cite

show abstract

“…1 54 b2 drugs from metered dose inhaler cartridges inserted into the breathing circuit 55 or nebulized drugs can be delivered via the tracheal tube, inhalation anaesthetic agents by vaporizers on anaesthetic machines, or by special equipment able to deliver inhalation agents through intensive care ventilators. 56 Weaning from ventilation and extubation requires the elimination of bronchoconstriction and extubation may itself provoke bronchospasm.…”

Section: Bjamentioning

confidence: 99%

Inhaled and intravenous treatment in acute severe and life-threatening asthma

Sellers

2013

British Journal of Anaesthesia

View full text Add to dashboard Cite

Management of life-threatening acute severe asthma in children and adults may require anaesthetic and intensive care. The inhaled route for drug delivery is not appropriate when only small respiratory gas volumes are shifted; the i.v. route may be associated with greater side-effects. Magnesium sulphate i.v. has a place in acute asthma management because it is a mild bronchodilator, and has a stabilizing effect on the atria which may attenuate tachycardia occurring after inhaled and i.v. salbutamol. If intubation and ventilation are required, a reduction in bronchoconstriction by any means before and during these procedures should reduce morbidity. This narrative review aims to show strengths and weakness of the evidence, present controversies, and forward opinions of the author. The review contains a practical guide to the setting up, use and efficiency of nebulizers, metered dose inhalers, and spacers (chambers). It also presents a commonsense approach to the management of severe asthmatics in whom delay in bronchodilatation would cause clinical deterioration. When self-inhaled agents have had no effect, i.v. drugs may help avoid intubation and ventilation. The review includes suggestions for the use of inhaled anaesthetics, anaesthetic induction, and brief notes on subsequent ventilation of the lungs.

show abstract

Association hélium-sévoflurane : une thérapeutique de sauvetage dans l’asthme aigu grave

Landy¹,

Steiner²,

Pernod³

et al. 2009

Annales Françaises d'Anesthésie et de Réanimation

View full text Add to dashboard Cite

Use of the AnaConDa^™ anaesthetic delivery system in ICU

Cited by 4 publications

References 4 publications

VV‐ECMO as bridge and safety net for successful therapeutic polypragmasy in a case of influenza‐triggered near‐fatal asthma

VV‐ECMO as bridge and safety net for successful therapeutic polypragmasy in a case of influenza‐triggered near‐fatal asthma

Inhaled and intravenous treatment in acute severe and life-threatening asthma

Association hélium-sévoflurane : une thérapeutique de sauvetage dans l’asthme aigu grave

Contact Info

Product

Resources

About

Use of the AnaConDa™ anaesthetic delivery system in ICU

Cited by 4 publications

References 4 publications

VV‐ECMO as bridge and safety net for successful therapeutic polypragmasy in a case of influenza‐triggered near‐fatal asthma

VV‐ECMO as bridge and safety net for successful therapeutic polypragmasy in a case of influenza‐triggered near‐fatal asthma

Inhaled and intravenous treatment in acute severe and life-threatening asthma

Association hélium-sévoflurane : une thérapeutique de sauvetage dans l’asthme aigu grave

Contact Info

Product

Resources

About

Use of the AnaConDa^™ anaesthetic delivery system in ICU